Home

CARE CAPITAL II LLC

CIK 1212648 · last filed 2013-10-15

CARE CAPITAL II LLC is a corporate insider who has filed 10 SEC Form 4 insider transactions across 1 company since 2009. The most recent filing shows the insider sold $32.7K of ACUR on Oct 15, 2013. Across all open-market trades the lifetime net is −$10.6M, making them a net seller over the disclosed history. The firm reports its address in Princeton, NJ. 56 SEC filings were submitted jointly with CARE CAPITAL INVESTMENTS II LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

10

Lifetime Open-Market Net

-$10.59M

Filer Profile

Reported Address
47 HULFISH ST
STE 310
PRINCETON, NJ 08542
State of Incorporation
DE
Related Filers
CARE CAPITAL INVESTMENTS II LP — 56 joint filings, latest 2015-06-26
Care Capital Offshore Investments II LP — 56 joint filings, latest 2015-06-26
JAN LESCHLY — 9 joint filings, latest 2006-12-14
David Russ Ramsay — 7 joint filings, latest 2010-03-08
Care Capital III LLC — 4 joint filings, latest 2015-06-26
Care Capital Investments III L.P. — 4 joint filings, latest 2015-06-26
Care Capital Offshore Investments III LP — 4 joint filings, latest 2015-06-26
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ACURA PHARMACEUTICALS, INC (ACUR) Delisted 10%+ Owner 861,908 — — -$10.59M 10 2013-10-15

Recent Filings

10 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2013-10-15 ACURA PHARMACEUTICALS, INC (ACUR) Delisted Sell (S) −16,200 -$32.7K EDGAR
2013-06-27 ACURA PHARMACEUTICALS, INC (ACUR) Delisted Sell (S) −228,843 -$460.8K EDGAR
2013-05-13 ACURA PHARMACEUTICALS, INC (ACUR) Delisted Sell (S) −777,000 -$1.70M EDGAR
2013-05-08 ACURA PHARMACEUTICALS, INC (ACUR) Delisted Sell (S) −186,000 -$399.9K EDGAR
2013-04-24 ACURA PHARMACEUTICALS, INC (ACUR) Delisted Sell (S) −2,445,000 -$7.05M EDGAR
2013-03-26 ACURA PHARMACEUTICALS, INC (ACUR) Delisted Sell (S) −118,662 -$257.4K EDGAR
2013-03-20 ACURA PHARMACEUTICALS, INC (ACUR) Delisted Sell (S) −94,125 -$222.1K EDGAR
2009-05-22 ACURA PHARMACEUTICALS, INC (ACUR) Delisted Sell (S) −24,000 -$176.2K EDGAR
2009-05-19 ACURA PHARMACEUTICALS, INC (ACUR) Delisted Sell (S) −5,352 -$37.7K EDGAR
2009-03-26 ACURA PHARMACEUTICALS, INC (ACUR) Delisted Sell (S) −35,000 -$248.8K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.